Labels Offer FDA Clues To Spiked Supplements, Health Fraud
This article was originally published in The Tan Sheet
Executive Summary
Claims that promise too much point FDA to products marketed as supplements that warrant investigation for health fraud, CFSAN’s Corey Hilmas tells USP workshop on economically motivated adulteration.
You may also be interested in...
Kratom Action Presents Regulatory Puzzle For FDA
The agency is seizing imports of kratom but industry seeks to clarify whether the substance, which in large doses can have narcotic effects, can be used in dietary supplements. Because FDA acknowledges kratom is a dietary ingredient, a ban as used for ephedra action may be up for consideration.
Kratom Action Presents Regulatory Puzzle For FDA
The agency is seizing imports of kratom but industry seeks to clarify whether the substance, which in large doses can have narcotic effects, can be used in dietary supplements. Because FDA acknowledges kratom is a dietary ingredient, a ban as used for ephedra action may be up for consideration.
Gaps In Spiked Supplement Net Could Shrink With Non-Targeted Screening
FDA plans to deploy testing technology that casts a wider net than its existing targeted adulterant tests, intending to catch product that may be tainted with as-yet-unknown adulterants.